Gastric Cancer,Gastrointestinal Cancer,Pancreatic Cancer,SCC (Squamous Cell Carcinoma),Skin Cancer Anlotinib + Chemotherapy: Effective Option for LM CRC Jan 22, 2024
Gastrointestinal Cancer,Gynecologic Cancer,Ovarian Cancer,Pancreatic Cancer HuCART-Meso and VCN-01 Combo in Pancreatic & Ovarian Cancer Jan 19, 2024
Gastrointestinal Cancer,Liver Cancer Atezolizumab+Bevacizumab: Etiological Influence on HCC Outcomes Jan 17, 2024
Gastric Cancer,Gastrointestinal Cancer Immune-Related Toxicity Decoded: Single-Cell Analysis and ICEMELT Risk Factors Jan 15, 2024
Colorectal Cancer,Gastrointestinal Cancer Efficacy of Lenvatinib + Pembrolizumab in mCRC Jan 15, 2024
Gastrointestinal Cancer,Head & Neck Cancer,Pancreatic Cancer LYT-200/Tislelizumab Shows Efficacy in R/R Cancers Jan 11, 2024
Gastric Cancer,Gastrointestinal Cancer,Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCC (Squamous Cell Carcinoma),Skin Cancer MCLA-129 + Osimertinib: Promising Early Results in EGFRmut NSCLC Jan 08, 2024
Colorectal Cancer,Gastrointestinal Cancer Fruquintinib Alone vs. Combo With ICIs in MSS mCRC Jan 05, 2024
